Skip to content
55

nicotinamide riboside

Worth a look

Shows low returns (0.1%), but a small market ($55K/yr) keeps it on the watch list.

Market size 14Growth 16Conversion 58Competition 44Returns 99Price range 88Avg price 95Brand share 77Review moat 87Quality gap 68

Returns

Incredible0.1%

return rate — above 5% kills the launch gate

Avg price

Incredible£24.25

avg listing price — sweet spot $15–$100

Price range

Great£7.09–£98.03

cheapest to priciest tracked listing — scored on the share inside $15–$100

Review moat

Great262.96

avg incumbent reviews — the moat a new listing must climb

Brand share

Great58%

top-5 brand share — no brand owns this niche

Quality gap

Good4.3★

avg incumbent rating — lower means beatable quality

Conversion

Good5.0%

search→purchase rate — share of searches ending in a sale

Competition

Okay58%

top-5 click share — leaders hold, buyers still browse

Growth

Bad-17.9%

90-day search growth — must beat 0% to launch

Market size

Bad£55K

£55K/yr · 45K searches